127 related articles for article (PubMed ID: 25914165)
21. A Surveillance, Epidemiology, and End Results analysis of small cell carcinoma of the bladder: epidemiology, prognostic variables, and treatment trends.
Koay EJ; Teh BS; Paulino AC; Butler EB
Cancer; 2011 Dec; 117(23):5325-33. PubMed ID: 21567387
[TBL] [Abstract][Full Text] [Related]
22. Pathological evaluation and quality of surgery in radical cystectomy in New South Wales, Australia.
Ahmadi N; Delprado WJ; Brooks AJ; Brenner PC; Coombes GM; Grant A; Patel MI
ANZ J Surg; 2015 Mar; 85(3):145-9. PubMed ID: 25410154
[TBL] [Abstract][Full Text] [Related]
23. Use of bacillus Calmette-Guérin in stage T1 bladder cancer: Long-term observation of a population-based cohort.
Patschan O; Holmäng S; Hosseini A; Liedberg F; Ljungberg B; Malmström PU; Rosell J; Jahnson S
Scand J Urol; 2015 Apr; 49(2):127-32. PubMed ID: 25331368
[TBL] [Abstract][Full Text] [Related]
24. Ras association domain family 1A: a promising prognostic marker in recurrent nonmuscle invasive bladder cancer.
Kim JS; Chae Y; Ha YS; Kim IY; Byun SS; Yun SJ; Kim WJ
Clin Genitourin Cancer; 2012 Jun; 10(2):114-20. PubMed ID: 22382007
[TBL] [Abstract][Full Text] [Related]
25. Sex differences in bladder cancer pathology and survival: analysis of a population-based cancer registry.
Zaitsu M; Toyokawa S; Tonooka A; Nakamura F; Takeuchi T; Homma Y; Kobayashi Y
Cancer Med; 2015 Mar; 4(3):363-70. PubMed ID: 25533611
[TBL] [Abstract][Full Text] [Related]
26. Bladder cancer in Spain 2011: population based study.
Miñana B; Cózar JM; Palou J; Unda Urzaiz M; Medina-Lopez RA; Subirá Ríos J; de la Rosa-Kehrmann F; Chantada-Abal V; Lozano F; Ribal MJ; Rodríguez Fernández E; Castiñeiras Fernández J; Concepción Masip T; Requena-Tapia MJ; Moreno-Sierra J; Hevia M; Gómez Rodríguez A; Martínez-Ballesteros C; Ramos M; Amón Sesmero JH; Pizá Reus P; Bohorquez Barrientos A; Rioja Sanz C; Gomez-Pascual JA; Hidalgo Zabala E; Parra Escobar JL; Serrano O
J Urol; 2014 Feb; 191(2):323-8. PubMed ID: 23994371
[TBL] [Abstract][Full Text] [Related]
27. Effects of age and comorbidity on treatment and survival of patients with muscle-invasive bladder cancer.
Goossens-Laan CA; Leliveld AM; Verhoeven RH; Kil PJ; de Bock GH; Hulshof MC; de Jong IJ; Coebergh JW
Int J Cancer; 2014 Aug; 135(4):905-12. PubMed ID: 24420527
[TBL] [Abstract][Full Text] [Related]
28. Bladder cancer incidence and mortality in patients treated with radiation for uterine cancer.
Baack Kukreja JE; Scosyrev E; Brasacchio RA; Toy EP; Messing EM; Wu G
BJU Int; 2014 Dec; 114(6):844-51. PubMed ID: 26010047
[TBL] [Abstract][Full Text] [Related]
29. Sex differences in bladder cancer outcomes among smokers with advanced bladder cancer.
Boström PJ; Alkhateeb S; Trottier G; Athanasopoulos PZ; Mirtti T; Kortekangas H; Laato M; van Rhijn B; van der Kwast T; Fleshner NE; Jewett MA; Finelli A; Zlotta AR
BJU Int; 2012 Jan; 109(1):70-6. PubMed ID: 21851540
[TBL] [Abstract][Full Text] [Related]
30. Young-onset colorectal cancer in New South Wales: a population-based study.
Boyce S; Nassar N; Lee CY; Suen MK; Al Zahrani S; Gladman MA
Med J Aust; 2016 Nov; 205(10):465-470. PubMed ID: 27852185
[TBL] [Abstract][Full Text] [Related]
31. Gender-specific outcomes of bladder cancer patients: a stage-specific analysis in a contemporary, homogenous radical cystectomy cohort.
Soave A; Dahlem R; Hansen J; Weisbach L; Minner S; Engel O; Kluth LA; Chun FK; Shariat SF; Fisch M; Rink M
Eur J Surg Oncol; 2015 Mar; 41(3):368-77. PubMed ID: 24674298
[TBL] [Abstract][Full Text] [Related]
32. Does patient age affect survival after radical cystectomy?
Horovitz D; Turker P; Bostrom PJ; Mirtti T; Nurmi M; Kuk C; Kulkarni G; Fleshner NE; Finelli A; Jewett MA; Zlotta AR
BJU Int; 2012 Dec; 110(11 Pt B):E486-93. PubMed ID: 22551360
[TBL] [Abstract][Full Text] [Related]
33. Bladder conservation treatment in the elderly population: results and prognostic factors of muscle-invasive bladder cancer.
Tran E; Souhami L; Tanguay S; Rajan R
Am J Clin Oncol; 2009 Aug; 32(4):333-7. PubMed ID: 19381080
[TBL] [Abstract][Full Text] [Related]
34. Prognostic significance of non-muscle-invasive bladder tumor history in patients with upper urinary tract urothelial carcinoma.
Milojevic B; Djokic M; Sipetic-Grujicic S; Grozdic Milojevic I; Vuksanovic A; Nikic P; Vukovic I; Djordjevic D; Bumbasirevic U; Tulic C
Urol Oncol; 2013 Nov; 31(8):1615-20. PubMed ID: 22521771
[TBL] [Abstract][Full Text] [Related]
35. Clinical features of leiomyosarcoma of the urinary bladder: analysis of 183 cases.
Rodríguez D; Preston MA; Barrisford GW; Olumi AF; Feldman AS
Urol Oncol; 2014 Oct; 32(7):958-65. PubMed ID: 25027684
[TBL] [Abstract][Full Text] [Related]
36. Long-term outcome of hematuria home screening for bladder cancer in men.
Messing EM; Madeb R; Young T; Gilchrist KW; Bram L; Greenberg EB; Wegenke JD; Stephenson L; Gee J; Feng C
Cancer; 2006 Nov; 107(9):2173-9. PubMed ID: 17029275
[TBL] [Abstract][Full Text] [Related]
37. Effect of gender on outcomes following radical cystectomy for urothelial carcinoma of the bladder: a critical analysis of 1,994 patients.
Mitra AP; Skinner EC; Schuckman AK; Quinn DI; Dorff TB; Daneshmand S
Urol Oncol; 2014 Jan; 32(1):52.e1-9. PubMed ID: 24239476
[TBL] [Abstract][Full Text] [Related]
38. The burden of bladder cancer in men and women: analysis of the years of life lost.
Scosyrev E; Golijanin D; Wu G; Messing E
BJU Int; 2012 Jan; 109(1):57-62. PubMed ID: 21883817
[TBL] [Abstract][Full Text] [Related]
39. Trends in the survival of patients diagnosed with kidney or urinary bladder cancer in the Nordic countries 1964-2003 followed up to the end of 2006.
Engholm G; Hakulinen T; Gislum M; Tryggvadóttir L; Klint A; Bray F; Storm HH
Acta Oncol; 2010 Jun; 49(5):655-64. PubMed ID: 20156116
[TBL] [Abstract][Full Text] [Related]
40. Analysis of 10-year cause-specific mortality of patients with breast cancer treated in New South Wales in 1995.
Wang W; O'Connell D; Stuart K; Boyages J
J Med Imaging Radiat Oncol; 2011 Oct; 55(5):516-25. PubMed ID: 22008173
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
